Biohit Oyj Interim report Q1-2013
AACC American Association for Clinical Chemistry
Houston, Texas, USA
Biohit HealthCare's unique GastroPanel examinations diagnose diseases of the stomach
and the risks associated with these diseases. Our quick tests provide diagnosis
of lactose intolerance and Helicobacter
pylori infection, as well as fecal occult blood, a well-known marker for
colorectal cancer. Instruments for analysing the test results are also available in our product range.
The new over-the-counter products eliminate carcinogenic acetaldehyde thus reducing the risk of cancers of the gastrointestinal tract.
Biohit Oyj sold its liquid handling segment to Sartorius Lab Holding GmbH in December 2011. Read more about Sartorius Biohit Liquid Handling Oy.
Biohit is a main sponsor of Healthy Stomach Initiative,
read more: www.hsinitiative.org